Compositions and methods comprising an EGFL7 antagonist for modulating vascular development

Details for Australian Patent Application No. 2011211408 (hide)

Owner Genentech, Inc.

Inventors Filvaroff, Ellen; Hongo, Jo-Anne S.; Parker IV, Leon H.; Schmidt, Maike; Ye, Weilan

Agent Griffith Hack

Pub. Number AU-A-2011211408

Parent 2005249377

Filing date 12 August 2011

Wipo publication date 1 September 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 August 2011 Complete Application Filed

1 September 2011 Application Open to Public Inspection

  Published as AU-A-2011211408

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011211409-Labeled transition metal complexes

2011211407-Audio video distribution system using multiple network speaker nodes in a multi speaker session